How Do Regulatory Bodies Assess the Long-Term Safety of Longevity Peptides?
Regulatory bodies meticulously evaluate longevity peptides through preclinical and multi-phase clinical trials, assessing long-term safety, immunogenicity, and systems-wide endocrine impacts.
∞ Biological Messengers
∞ Quality Control
∞ Hormonal Balance